Attached files

file filename
8-K - FORM 8-K - ACCENTIA BIOPHARMACEUTICALS INCd8k.htm

Exhibit 99.1

SCHEDULE OF RECEIPTS AND DISBURSEMENTS

 

FOR THE PERIOD BEGINNING: September 1, 2009

     Period ending September 30, 2009

Name of Debtor:    Accentia Biopharmaceuticals, Inc.

     Case Number: 8:08-bk-17795-KRM
Date of Petition:    November 10, 2008     

 

         CURRENT MONTH        CUMULATIVE
PETITION TO DATE

1.    FUNDS AT BEGINNING OF PERIOD

  $ 8,078.38        $ 281,590.31

2.    RECEIPTS:

            

A.  Cash Sales

            

B.  Accounts Receivable

            

C.  Other Receipts (See MOR-3)

    10,803.02          405,147.73

D.  Transfer from subsidiaries - TEAMM

    —            215,644.58

     - Analytica

    153,000.00          1,581,088.38

     - A.S.P.

    —            30,731.41

     - AccentRx

    —            4,327.23

     - Biovest (shared expenses)

    70,000.00          410,166.60

3.    TOTAL RECEIPTS (Lines 2A+2B+2C)

    233,803.02          2,647,105.93

4.    TOTAL FUNDS AVAILABLE FOR OPERATIONS (1+3)

    241,881.40          2,928,696.24

5.    DISBURSEMENTS

            

A.   Advertising

    —            —  

B.   Bank Charges / Payroll Fees

    1,266.15          16,011.15

C.   Contract Labor

    —            —  

D.   Fixed Asset Payments (not incl in N)

    —            —  

E.   Insurance

    18,650.69          631,216.00

F.   Inventory Payments (See Attach. 2)

    —            —  

G.   Leases

    —            9,476.21

H.   Manufacturing Supplies

    —            —  

I.   Office Supplies

    1,381.78          21,922.23

J.   Payroll – Net (see Attachment 4B)

    121,867.88          1,013,471.49

K.   Professional Fees (Accounting/Legal)

    20,980.00          168,500.16

L.   Rent

    14,872.82          164,182.86

M.  Repairs and Maintenance

    —            360.00

N.   Secured Creditor Payments (Attach. 2)

    —            —  

O.   Taxes Paid – Payroll (Attach. 4C)

    24,109.75          394,501.85

P.   Taxes Paid – Sales and Use (Attach. 4C)

    —            —  

Q.   Taxes Paid – Other (Attach. 4C)

    —            1,000.00

R.   Telephone / Internet

    7,857.92          82,057.67

S.   Travel and Entertainment

    377.85          19,546.07

Y.   U.S. Trustee Quarterly Fees

    —            35,100.00

U.   Utilities

    —            819.31

V.   Vehicle Expenses

    —            —  

W.  Other Operating Expenses (See MOR-3)

    —            34,929.71

X.   Transfer to subsidiaries - Analytica

    27,000.00          307,084.97

    - Biovest (shared expenses)

    —            25,000.00

TOTAL DISBURSEMENTS (Sum of 5A thru W)

    238,364.84          2,925,179.68

ENDING BALANCE (Line 4 Minus Line 6)(c)

    3,516.56          3,516.56

I declare under penalty of perjury that this statement and the accompanying documents and reports are true and correct to the best of my knowledge and belief.

 

This 22nd day of October, 2009

 

/s/ Alan M. Pearce

 

(Signature)

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) This figure will not change from month to month. It is always the amount of funds on hand as of the date of the petition.
(c) These two amounts will always be the same if form is completed correctly.

 

MOR-1


MONTHLY SCHEDULE OF RECEIPTS AND DISBURSEMENTS (cont’d)

Detail of Other Receipts and Other Disbursements

OTHER RECEIPTS:

Describe Each Item of Other Receipt and List Amount of Receipt. Write totals on Page MOR-2, Line 2C.

 

        Description   

Current Month 

  

Cumulative

Petition to Date 

           

Collections for TEAMM receivables and Cobra

   $ —       $ 254,474.27 

Rent reimbursement from BDSI

     —         12,530.08 

Workers compensation refund

     —         4,788.48 

Collections for A.S.P. receivables

     3,705.57       49,045.57 

COBRA checks for Accentia

     7,097.45       84,309.33 

TOTAL OTHER RECEIPTS

   $ 10,803.02     $ 405,147.73 
               
               

“Other Receipts” includes Loans from Insiders and other sources (i.e. Officer/Owner, related parties directors, related corporations, etc.). Please describe below: N/A

 

Loan Amount    Source of Funds    Purpose    Repayment Schedule

N/A

              

                    

              

                    

              

                    

              

                    

              

OTHER DISBURSEMENTS:

Describe Each Item of Other Disbursement and List Amount of Disbursement. Write totals on Page MOR-2, Line 5W.

 

        Description   

Current Month 

  

Cumulative

Petition to Date 

           

Southeastern Document Service – document handling for bankruptcy filing

   $    $ 1,247.60 

RR Donnelly – SEC filings

   $    $ 4,700.00 

Garrison Hasara – overnight postage charge for payroll disbursement (Fed-Ex refused service)

   $    $ 1,087.24 

Florida Department of State

   $    $ 600.00 

Settlement with DDN

   $    $ 7,500.00 

Bill McNulty – moving expenses (closed 2nd floor of Tampa office)

   $    $ 986.57 

Promontech – sample inventory destruction

   $    $ 18,808.30 

TOTAL OTHER DISBURSEMENTS

   $    $ 34,929.71 

NOTE: Attach a current Balance Sheet and Income (Profit & Loss) Statement.

 

MOR-2


ATTACHMENT 1

MONTHLY ACCOUNTS RECEIVABLE RECONCILIATION AND AGING

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009    Period ending September 30, 2009

 

ACCOUNTS RECEIVABLE AT PETITION DATE:   

    N/A

  

ACCOUNTS RECEIVABLE RECONCILIATION

(Include all accounts receivable, pre-petition and post-petition, including charge card sales which have not been received):

 

Beginning of Month Balance (a)

   $

PLUS: Current Month New Billings

  

MINUS: Collection During the Month(b)

   $

PLUS/MINUS: Adjustments or Write-offs*

   $

End of Month Balance(c)

   $

 

* For any adjustments or Write-offs provide explanation and supporting documentation, if applicable:

 

 

 

POST PETITION ACCOUNTS RECEIVABLE AGING

(Show the total for each aging category for all accounts receivable)

 

0-30 Days   31-60 Days   61-90 Days   Over 90Days   Total(c)
$     $     $     $     $

For any receivables in the “Over 90 Days” category, please provide the following: N/A

 

Receivable Customer    Date     

Status (Collection efforts taken,

estimate of collectability, write-off,

disputed account, etc.)

N/A          
                              
                              
                              

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) This must equal the number reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 2B).
(c) These two amounts must equal.

 

MOR-3


ATTACHMENT 2

MONTHLY ACCOUNTS PAYABLE AND SECURED PAYMENTS REPORT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009    Period ending September 30, 2009

In the space below list all invoices or bills incurred and not paid since the filing of the petition. Do not include amounts owed prior to filing the petition. In the alternative, a computer generated list of payables may be attached provided all information requested below is included. SEE ATTACHED

POST-PETITION ACCOUNTS PAYABLE

 

Date Incurred    Date Outstanding    Vendor    Description    Amount

See attached

                   

                    

                 

                    

                   

                    

                   
              

TOTAL AMOUNT(b)

    

 

¨ Check here if pre-petition debts have been paid. Attach an explanation and copies of supporting documentation.

 

 

ACCOUNTS PAYABLE RECONCILIATION (Post Petition Unsecured Debt Only)

 

Opening Balance(a)

   $ 180,843.71   

PLUS: New Indebtedness Incurred This Month

     54,006.42   

MINUS: Amount Paid on Post Petition, Accounts Payable This Month

     (65,387.21

PLUS/MINUS: Adjustments*

     *   

Ending Month Balance(c)

   $ 169,462.92   

 

* For any adjustments provide explanation and supporting documentation, if applicable.

 

 

 

SECURED PAYMENTS REPORT

List the status of Payments to Secured Creditors and Lessors (Post Petition Only). If you have entered into a modification agreement with a secured creditor/lessor, consult with your attorney and the United States Trustee Program prior to completing this section).

 

Secured Creditor/Lessor   Date
Payment        
Due This
Month
  Amount
Paid This        
Month
  Number of
Post Petition        
Payments
Delinquent
  Total Amount of        
Post Petition
Payments
Delinquent

N/A

               

                    

               

                    

               

Total(d)

               

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be zero.
(b, c) The total of line (b) must equal line (c).
(d) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line5N).

 

MOR-4


ATTACHMENT 3

INVENTORY AND FIXED ASSETS REPORT

 

Name of Debtor:    Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009    Period ending September 30, 2009

INVENTORY REPORT

 

INVENTORY BALANCE AT PETITION DATE:

   $       N/A

INVENTORY RECONCILIATION:

        

Inventory Balance at Beginning of Month(a)

   $      

PLUS: Inventory Purchased During Month

   $      

MINUS: Inventory Used or Sold

   $      

PLUS/MINUS: Adjustments or Write-downs*

   $      

Inventory on Hand at End of Month

   $      

 

METHOD OF COSTING INVENTORY:  

 

 

 

* For any adjustments or write-downs provide explanation and supporting documentation, if applicable.

 

 

INVENTORY AGING

 

Less than 6

months old

  

6 months to 2

years old

   Greater than 2
years old
   Considered
Obsolete
       Total  
%    %    %    %   =    100 %* 

 

* Aging Percentages must equal 100%.
¨ Check here if inventory contains perishable items.

 

Description of Obsolete Inventory:  

 

FIXED ASSET REPORT

 

FIXED ASSETS FAIR MARKET VALUE AT PETITION DATE(b):    $95,604.47  

(Includes Property, Plant and Equipment)

 

BRIEF DESCRIPTION (First Report Only):  

 

 

FIXED ASSETS RECONCILIATION:

 

Fixed Asset Book Value at Beginning of Month(a) (b)

   $ 52,877.08

MINUS: Depreciation Expense

   $ 3,018.78

PLUS: New Purchases

     —  

PLUS/MINUS: Adjustments or Write-downs*

     —  

Ending Monthly Balance

   $ 49,858.30

 

* For any adjustments or write-downs, provide explanation and supporting documentation, if applicable.

 

BRIEF DESCRIPTION OF FIXED ASSETS PURCHASED OR DISPOSED OF DURING THE

REPORTING PERIOD:        N/A                                                                                                              

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) Fair Market Value is the amount at which fixed assets could be sold under current economic conditions. Book Value is the cost of the fixed assets minus accumulated depreciation and other adjustments.

 

MOR-5


ATTACHMENT 4A

MONTHLY SUMMARY OF BANK ACTIVITY—OPERATING ACCOUNT

 

Name of Debtor:    Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009    Period ending September 30, 2009

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm. If bank accounts other than the three required by the United States Trustee Program are necessary, permission must be obtained from the United States Trustee prior to opening the accounts. Additionally, use of less than the three required bank accounts must be approved by the United States Trustee.

 

NAME OF BANK:  Wachovia Bank, NA   BRANCH:  

 

 
ACCOUNT NAME: Accentia Master Account DIP   ACCOUNT NUMBER:  *********1478

 

PURPOSE OF ACCOUNT:  

        MASTER ACCOUNT

 

 

Ending Balance per Bank Statement

   $0

Plus Total Amount of Outstanding Deposits

   $0

Minus Total Amount of Outstanding Checks and other debits*

   $0

Minus Service Charges

   $0

Ending Balance per Check Register**(a)

   $0

 

*Debit cards are used by        N/A                                                                                                                                               
**If Closing Balance is negative, provide explanation:        N/A                                                                                                  

The following disbursements were paid in Cash (do not include items reported as Petty Cash on Attachment 4D:    (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date    Amount    Payee    Purpose    Reason for Cash Disbursement
                 
         
                     
                 
         
                     
                 
         
                     

TRANSFERS BETWEEN DEBTOR IN POSSESSION ACCOUNTS

“Total Amount of Outstanding Checks and other debits”, listed above, includes:

 

$                    Transferred to Payroll Account

$                    Transferred to Tax Account

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-6


ATTACHMENT 5A

CHECK REGISTER - OPERATING ACCOUNT

 

Name of Debtor:     Accentia Biopharmaceuticals, Inc.   Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009   Period ending September 30, 2009
NAME OF BANK:  Wachovia Bank, NA   BRANCH:  

        Tampa

ACCOUNT NAME: Accentia Operating   ACCOUNT NUMBER:  *********1478
PURPOSE OF ACCOUNT:  

            MASTER ACCOUNT

  

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included.  NONE

 

  DATE            

 

  CHECK

  NUMBER        

    PAYEE     PURPOSE     AMOUNT          
     
                 
          Account closed to reduce fees            
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
            TOTAL   $

 

MOR-7


ATTACHMENT 4A2

MONTHLY SUMMARY OF BANK ACTIVITY - OPERATING ACCOUNT

 

Name of Debtor:     Accentia Biopharmaceuticals, Inc.   Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009   Period ending September 30, 2009

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm. If bank accounts other than the three required by the United States Trustee Program are necessary, permission must be obtained from the United States Trustee prior to opening the accounts. Additionally, use of less than the three required bank accounts must be approved by the United States Trustee.

 

NAME OF BANK:  Wachovia Bank, NA   BRANCH:  

 

ACCOUNT NAME: Accentia Operating Account DIP   ACCOUNT NUMBER:  *********1494

 

PURPOSE OF ACCOUNT:    

            OPERATING

 

 

Ending Balance per Bank Statement

   $11,937.45

Plus Total Amount of Outstanding Deposits

   $0

Minus Total Amount of Outstanding Checks and other debits*

   $8,420.89

Minus Service Charges

   $0

Ending Balance per Check Register**(a)

   $3,516.56

  *Debit cards are used by N/A                                        

  **If Closing Balance is negative, provide explanation:           ZBA bank account balance always zero        

 

 

  

 

 

The following disbursements were paid in Cash (do not include items reported as Petty Cash on Attachment 4D:     (¨ Check here if cash disbursements were authorized by United States Trustee)

 

  Date            

    Amount         Payee                             Purpose     Reason for Cash Disbursement
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 
     
                 

 

MOR-8


ATTACHMENT 5A2

CHECK REGISTER - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.     Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009     Period ending September 30, 2009
NAME OF BANK: Wachovia Bank, NA     BRANCH:  

      Tampa

ACCOUNT NAME: Accentia Operating     ACCOUNT NUMBER:    *********1494
PURPOSE OF ACCOUNT:  

        OPERATING

  

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included. SEE SEPARATE REGISTER

 

DATE    CHECK
NUMBER
   PAYEE    PURPOSE    AMOUNT
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
       
                     
               TOTAL    $

 

MOR-9


ATTACHMENT 4B

MONTHLY SUMMARY OF BANK ACTIVITY - PAYROLL ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.       Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009       Period ending September 30, 2009
Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm.
NAME OF BANK:  

  N/A                    

      BRANCH:  

      N/A

ACCOUNT NAME:  

 

    ACCOUNT NUMBER:   

 

PURPOSE OF ACCOUNT:  

        PAYROLL

  

 

Ending Balance per Bank Statement

   $                                        

Plus Total Amount of Outstanding Deposits

   $

Minus Total Amount of Outstanding Checks and other debits*

   $

Minus Service Charges

   $

Ending Balance per Check Register**(a)

   $

 

* Debit cards must not be issued on this account.
** If Closing Balance is negative, provide explanation:                                                          

The following disbursements were paid by Cash: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date    Amount    Payee    Purpose   

Reason for Cash

Disbursement

       
                     
       
                     
       
                     
       
                     
       
                     

The following non-payroll disbursements were made from this account:

 

Date    Amount    Payee    Purpose   

Reason for Disbursement

from account

       
                     
       
                     
       
                     
       
                     
       
                     

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-10


ATTACHMENT 5B

CHECK REGISTER - PAYROLL ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

  

Case Number: 8:08-bk-17795-KRM

 

Reporting Period beginning September 1, 2009

  

Period ending September 30, 2009

 

 

NAME OF BANK:

 

      N/A

      BRANCH:  

      N/A

 

ACCOUNT NAME:

 

 

       ACCOUNT NUMBER:  

 

   

PURPOSE OF ACCOUNT:

 

                PAYROLL

   

Account for all disbursements, including voids, lost payments, stop payment, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included.

 

DATE  

CHECK

NUMBER

   PAYEE    PURPOSE   AMOUNT

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                 

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

                 

                

           

TOTAL

  $

 

MOR-11


ATTACHMENT 4C

MONTHLY SUMMARY OF BANK ACTIVITY - TAX ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

  

Case Number: 8:08-bk-17795-KRM

 

Reporting Period beginning September 1, 2009

  

Period ending September 30, 2009

 

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found on the United States Trustee website, http://www.usdoj.gov/ust/r21/index.htm.

 

NAME OF BANK:

 

      N/A

      BRANCH:  

      N/A

 

ACCOUNT NAME:

 

 

       ACCOUNT NUMBER:  

 

   

PURPOSE OF ACCOUNT:

 

                TAX

   

 

Ending Balance per Bank Statement

  $                                 

Plus Total Amount of Outstanding Deposits

  $  

Minus Total Amount of Outstanding Checks and other debits*

  $  

Minus Service Charges

  $  

Ending Balance per Check Register**(a)

  $  

*Debit cards must not be issued on this account.

**If Closing Balance is negative, provide explanation:                    N/A                                         

The following disbursements were paid by Cash: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date   Amount    Payee    Purpose   Reason for Cash Disbursement
                                  
                                  
                                  

The following non-tax disbursements were made from this account: N/A

 

Date   Amount    Payee    Purpose  

Reason for Disbursement

from account

                                  
                                  
                                  
                                  
                                  

 

  (a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-12


ATTACHMENT 5C

CHECK REGISTER - TAX ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.

  

Case Number: 8:08-bk-17795-KRM

 

Reporting Period beginning September 1, 2009

  

Period ending September 30, 2009

 

 

NAME OF BANK:

 

      N/A

      BRANCH:  

      N/A

 

ACCOUNT NAME:

 

 

       ACCOUNT NUMBER:  

 

   

PURPOSE OF ACCOUNT:

 

                TAX

   

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer-generated check register can be attached to this report, provided all the information requested below is included.

 

DATE  

CHECK

NUMBER

   PAYEE    PURPOSE   AMOUNT
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                             TOTAL(d)   $

*This amount was paid by check through the Accentia Operating Account.

SUMMARY OF TAXES PAID

 

Payroll Taxes Paid (a)

           $ 24,109.78

Sales & Use Taxes Paid(b)

           $ 0

Other Taxes Paid (c)

           $ 0

TOTAL(d)

           $ 24,109.75

 

  (a) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5O).
  (b) This number is reported in the “Current Month” column of Schedule or Receipts and Disbursements (Page MOR-2, Line 5P).
  (c) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5Q).
  (d) These two lines must be equal.

 

MOR-13


ATTACHMENT 4D

INVESTMENT ACCOUNTS AND PETTY CASH REPORT

INVESTMENT ACCOUNTS

Each savings and investment account, i.e. certificates of deposits, money market accounts, stocks and bonds, etc., should be listed separately. Attach copies of account statements.

Type of Negotiable

 

Instrument  

Face

Value

 

Purchase

Price

 

Date of

Purchase

 

Current

Market

Value

N/A

               
                            
                            
                            
                            
                            
                            
            TOTAL(a)   $

PETTY CASH REPORT

The following Petty Cash Drawers/Accounts are maintained:

 

Location of Box/Account   

(Column 2)

Maximum

Amount of Cash

in Drawer/Acct.

  

(Column 3)

Amount of

Petty Cash

On Hand At

End of Month

  

(Column 4)

Difference

between

(Column 2)

and (Column 3)

N/A

              
                           
                           
                           
                           
                           
                           
          TOTAL(b)    $

For any Petty Cash Disbursements over $100 per transaction, attach copies of receipts. If there are no receipts, provide an explanation                                                                                                                          

TOTAL INVESTMENT ACCOUNTS AND PETTY CASH (a+ b)    $                                (c)

 

(c) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-14


ATTACHMENT 6

MONTHLY TAX REPORT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009    Period ending September 30, 2009

TAXES OWED AND DUE

Report all unpaid post-petition taxes including Federal and State withholding FICA, State sales tax, property tax, unemployment tax, State workmen’s compensation, etc.

 

Name of Taxing Authority    Date      
Payment Due      
   Description          Amount         

Date of      
Last Tax      
Return      

Filed      

   Tax Return      
Period      
N/A                           
                            
                            
                            
                            
                            
                            
          TOTAL    $            

 

MOR-15


ATTACHMENT 7

SUMMARY OF OFFICER OR OWNER COMPENSATION

SUMMARY OF PERSONNEL AND INSURANCE COVERAGES

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning September 1, 2009    Period ending September 30, 2009

Report all forms of compensation received by or paid on behalf of the Officer or Owner during the month. Include car allowances, payments to retirement plans, loan repayments, payments of Officer/Owner’s personal expenses, insurance premium payments, etc. Do not include reimbursement for business expenses Officer or Owner incurred and for which detailed receipts are maintained in the accounting records.

 

Name of Officer or Owner    Title    Payment
Description
   Amount Paid
Samuel Duffey    President, General Counsel    Salary    $ 20,692.31
Alan Pearce    C.F.O.    Salary      16,452.18
                  
                  

PERSONNEL REPORT

 

     Full Time    Part Time

Number of employees at beginning of period

   11    1

Number hired during the period

   0    0

Number terminated or resigned during period

   0    0

Number of employees on payroll at end of period

   11    1

 

 

CONFIRMATION OF INSURANCE

List all policies of insurance in effect, including but not limited to workers’ compensation, liability, fire, theft, comprehensive, vehicle, health and life. For the first report, attach a copy of the declaration sheet for each type of insurance. For subsequent reports, attach a certificate of insurance for any policy in which a change occurs during the month (new carrier, increased policy limits, renewal, etc.). SEE ATTACHED

 

Agent and/or Carrier   

Phone

Number

   Policy Number   

Coverage

Type

  

Expiration

Date

  

Date

Premium

Due

                          
                          

The following lapse in insurance coverage occurred this month: N/A

 

Policy Type    Date Lapsed   

Date

Reinstated

   Reason for Lapse
                
                

 

¨ Check here if U. S. Trustee has been listed as Certificate Holder for all insurance policies.

 

MOR-16


ATTACHMENT 8

SIGNIFICANT DEVELOPMENTS DURING REPORTING PERIOD

Information to be provided on this page, includes, but is not limited to: (1) financial transactions that are not reported on this report, such as the sale of real estate (attach closing statement); (2) non-financial transactions, such as the substitution of assets or collateral; (3) modifications to loan agreements; (4) change in senior management, etc. Attach any relevant documents. N/A

 

 
 
 
 
 
 
 
 
 

We anticipate filing a Plan of Reorganization and Disclosure Statement on or before         .

 

MOR-17